Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbohydrate-based Aspart Dosing in Inpatient Diabetes
NCT01333514Phase 4Terminated
- Sponsor
- Rush University Medical Center
- Start
- Apr 2011
- Primary completion
- Dec 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of insulin aspart in type 2 diabetes mellitus (T2DM), sponsored by Rush University Medical Center. Started Apr 2011; status: terminated.
02
Drugs
insulin aspart
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01333514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01333514.